Home > Healthcare > Pharmaceuticals > Disease Specific Drugs > Osteoarthritis Drugs Market

Osteoarthritis Drugs Market Share

Report ID: GMI8580
Published Date: Mar 2024
Report Format: PDF

Download Free Sample

Osteoarthritis Drugs Market Share

The competitive landscape of the osteoarthritis drugs industry is characterized by the presence of established companies vying for market share. Key players are engaging in strategic initiatives such as mergers, acquisitions, and partnerships to strengthen their product portfolios. The companies are actively adopting a multi-pronged approaches to address the rising demand for effective osteoarthritis drugs.

Osteoarthritis Drugs Market Companies

Prominent players operating in the market are as mentioned below:

Anika Therapeutics
Assertio Holdings, Inc.
Bayer AG
Bioventus
Ferring Pharmaceuticals Inc.
GlaxoSmithKline plc
Novartis AG
Pacira Pharmaceuticals, Inc
Pfizer Inc
Sanofi SA
Zimmer Biomet Holdings, Inc.

Authors: Mariam Faizullabhoy, Gauri Wani

Frequently Asked Questions (FAQ) :

The gas analyzer systems market in North America was reached USD 976.2 million in 2023 and is projected to record a CAGR of 5.3% through 2032, driven by the increasing adoption of online continuous monitoring systems and stringent environmental regulations aimed at reducing air pollution and emissions.

Electrochemical gas analyzer systems segment held a dominant market share in 2023 in North America and is poised to cross USD 460 million by 2032, driven by escalating emission levels across diverse end-use sectors.

U.S. gas analyzer systems industry surpass USD 1.10 billion by 2032, driven by the growing emphasis on improving industrial processes' efficiency and safety, along with technological advancements, particularly in sensor technology and data analytics.

ABB, Acoem., AMETEK. Inc., AVL, Dragerwerk AG & Co.KGaA, DURAG GROUP, Emerson ElectricCo.,ENVEA, Figaro Engineering Inc., General Electric, Honeywell International Inc are some of the major industry contenders.